BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioAtla's market cap was $2.18M on Oct 19, 2026, against $41.07M a year earlier. Over the last 5 years it ranged from $2.16M to $888.56M, with a median of $85.54M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $2.18M | -93.5% |
| 2025 | Dec 31, 2025 | $33.38M | +16.8% |
| 2024 | Dec 31, 2024 | $28.58M | -75.7% |
| 2023 | Dec 29, 2023 | $117.85M | -60.7% |
| 2022 | Dec 30, 2022 | $300.01M | -56.6% |
| 2021 | Dec 31, 2021 | $690.79M | – |
See a number that looks wrong?